News

November 7, 2014November 18, 2014

Personalized Medicine for NSCLC Patients Successful

Lung cancer News, News

Personalized medicine for lung cancer patients is on the horizon as a result of recommendations issued by the International Association for the Study of Lung Cancer (IASLC). As described in ... Read more

November 6, 2014November 18, 2014

Study Develops Risk Stratification Model For Lung Cancer Patients

News

A team of researchers led by Dr. Matthew Evison, from the University Hospital of South Manchester, United Kingdom, published this week in the Journal of Thoracic Oncology a study entitled ... Read more

November 5, 2014November 18, 2014

Early detection of Lung Cancer Using Circulating Tumor Cells In The Blood

News

A new study published in the journal PLOS One, entitled ““Sentinel” Circulating Tumor Cells Allow Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease“, has made an important ... Read more

November 4, 2014November 18, 2014

Lung Cancer Patients Treated With SBRT Reveal Excellent Sustained Local Control

News

A study presented at the 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology by Gregory M.M. Videtic, MD, a radiation oncologist at the Cleveland Clinic Foundation and associate professor of radiation ... Read more

October 31, 2014November 18, 2014

Post-Operative Radiation Therapy Adds 4 Months to Lung Cancer Survival

News

A recent data review on patients with non-small cell lung cancer revealed post-operative radiation therapy (PORT) prolonged survival by an average of 4 months compared to patients that did not ... Read more

October 31, 2014November 18, 2014

Bristol-Myers Squibb NSCLC Treatment Results Announced

Lung cancer News, News

Results from Bristol-Myers Squibb Company’s phase 2 clinical trial CheckMate -063 studying Opdivo (nivolumab) in patients with advanced squamous cell non-small cell lung cancer (NSCLC) indicated a 15% objective response ... Read more

October 29, 2014November 18, 2014

Pharmatech’s AccessPPM Research System Focuses On Lung Cancer Studies

News

After the launch of AccessPPM (Pharmatech Precision Medicine) Research System, Pharmatech is focusing on lung cancer using biomarker targeting in lung cancer studies. The company has ongoing clinical trials to assess the treatment outcomes of different molecular ... Read more

October 28, 2014November 18, 2014

KEYTRUDA Granted Breakthrough Therapy Designation by FDA For Lung Cancer Treatment

News

Merck’s KEYTRUDA (pembrolizumab), has been granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration (FDA) for the treatment of patients with Epidermal Growth Factor Receptor (EGFR) mutation-negative, and Anaplastic ... Read more

October 27, 2014November 18, 2014

Overall Survival High for Group of Stage IV NSCLC Patients

News

According to an abstract presented at the American Society for Radiation Oncology (ASTRO) 56th Annual Meeting in September, certain types of metastatic (stage IV) non-small cell lung cancers (NSCLC) can ... Read more

October 24, 2014November 18, 2014

Experimental Drug Shows Promise in Animal Models of Lung Cancer, According to Study

News

A recent study titled “TOPK inhibitor induces complete tumor regression in xenograft models of human cancer through inhibition of cytokinesis”, published in the journal Science Translation Medicine, showed that in ... Read more